176 related articles for article (PubMed ID: 19448114)
21. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted MR imaging of the gastrointestinal tract: technique, indications, and imaging findings.
Sinha R; Rajiah P; Ramachandran I; Sanders S; Murphy PD
Radiographics; 2013 May; 33(3):655-76; discussion 676-80. PubMed ID: 23674768
[TBL] [Abstract][Full Text] [Related]
24. MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images.
Thurnher SA
AJR Am J Roentgenol; 1992 Dec; 159(6):1243-50. PubMed ID: 1442393
[TBL] [Abstract][Full Text] [Related]
25. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases.
Rechichi G; Galimberti S; Signorelli M; Franzesi CT; Perego P; Valsecchi MG; Sironi S
AJR Am J Roentgenol; 2011 Jul; 197(1):256-62. PubMed ID: 21701038
[TBL] [Abstract][Full Text] [Related]
26. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
27. The value of the apparent diffusion coefficient in differentiating stage IA endometrial carcinoma from normal endometrium and benign diseases of the endometrium: initial study at 3-T magnetic resonance scanner.
Wang J; Yu T; Bai R; Sun H; Zhao X; Li Y
J Comput Assist Tomogr; 2010; 34(3):332-7. PubMed ID: 20498531
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted imaging of gynecologic tumors: diagnostic pearls and potential pitfalls.
Dhanda S; Thakur M; Kerkar R; Jagmohan P
Radiographics; 2014; 34(5):1393-416. PubMed ID: 25208287
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer.
Shen SH; Chiou YY; Wang JH; Yen MS; Lee RC; Lai CR; Chang CY
AJR Am J Roentgenol; 2008 Feb; 190(2):481-8. PubMed ID: 18212236
[TBL] [Abstract][Full Text] [Related]
30. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
Takeuchi M; Matsuzaki K; Nishitani H
J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
[TBL] [Abstract][Full Text] [Related]
31. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
[TBL] [Abstract][Full Text] [Related]
32. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis.
Mir N; Sohaib SA; Collins D; Koh DM
J Med Imaging Radiat Oncol; 2010 Aug; 54(4):358-64. PubMed ID: 20718916
[TBL] [Abstract][Full Text] [Related]
33. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
Giannarini G; Petralia G; Thoeny HC
Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
[TBL] [Abstract][Full Text] [Related]
34. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
[TBL] [Abstract][Full Text] [Related]
35. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations.
Kaur H; Choi H; You YN; Rauch GM; Jensen CT; Hou P; Chang GJ; Skibber JM; Ernst RD
Radiographics; 2012; 32(2):389-409. PubMed ID: 22411939
[TBL] [Abstract][Full Text] [Related]
36. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
Holzapfel K; Duetsch S; Fauser C; Eiber M; Rummeny EJ; Gaa J
Eur J Radiol; 2009 Dec; 72(3):381-7. PubMed ID: 18995981
[TBL] [Abstract][Full Text] [Related]
37. Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging.
Yoshida S; Masuda H; Ishii C; Saito K; Kawakami S; Kihara K
Int J Urol; 2008 Feb; 15(2):140-3. PubMed ID: 18269448
[TBL] [Abstract][Full Text] [Related]
38. Malignant tumors of the female pelvic floor: imaging features that determine therapy: pictorial review.
Lee SI; Oliva E; Hahn PF; Russell AH
AJR Am J Roentgenol; 2011 Mar; 196(3 Suppl):S15-23 Quis S24-7. PubMed ID: 21343531
[No Abstract] [Full Text] [Related]
39. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
